These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15852992)

  • 21. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy.
    Schmidt J; Muenster T; Wick S; Forst J; Schmitt HJ
    Br J Anaesth; 2005 Dec; 95(6):769-72. PubMed ID: 16183677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the neuromuscular effects of mivacurium and suxamethonium in infants and children.
    Cook DR; Gronert BJ; Woelfel SK
    Acta Anaesthesiol Scand Suppl; 1995; 106():35-40. PubMed ID: 8533543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery of train-of-four after mivacurium.
    Brull SJ; Connelly NR; Silverman DG
    Can J Anaesth; 1995 Jan; 42(1):28-31. PubMed ID: 7889581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Continuous administration of mivacurium for short procedures. Delayed onset and recovery from neuromuscular blockade].
    Pellissier D; Bruder N; Mokart D; Quilichini D; Camatte S; Blache JL; François G
    Ann Fr Anesth Reanim; 1995; 14(6):467-71. PubMed ID: 8745969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
    Lessard MR; Trépanier CA; Rouillard JF
    Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different priming techniques, including mivacurium, accelerate the onset of rocuronium.
    Naguib M
    Can J Anaesth; 1994 Oct; 41(10):902-7. PubMed ID: 8001208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mivacurium infusion requirement and spontaneous recovery of neuromuscular transmission in children anaesthetized with nitrous oxide and fentanyl, halothane, isoflurane or sevoflurane.
    Woloszczuk-Gebicka B
    Paediatr Anaesth; 2002 Jul; 12(6):511-8. PubMed ID: 12139592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in plasma cholinesterase activity and mivacurium neuromuscular block in response to normothermic cardiopulmonary bypass.
    Diefenbach C; Abel M; Rump AF; Grond S; Korb H; Buzello W
    Anesth Analg; 1995 Jun; 80(6):1088-91. PubMed ID: 7762834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery from mivacurium-induced neuromuscular blockade after neurosurgical procedures of long duration.
    Jellish WS; Thalji ZA; Murdoch JR
    J Clin Anesth; 1995 Dec; 7(8):643-7. PubMed ID: 8747563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infusion of mivacurium and atracurium guided by manual tactile evaluation].
    Pedersen NA; Østergaard D; Olsen JS; Munksgård AB; Hedengran AM
    Ugeskr Laeger; 2000 Nov; 162(48):6532-5. PubMed ID: 11187220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
    Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
    Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgeon-controlled mivacurium administration during elective caesarean section.
    Abdulatif M; Taylouni E
    Can J Anaesth; 1995 Feb; 42(2):96-102. PubMed ID: 7720168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mivacurium: dose-response relationship and administration by repeated injection or infusion.
    Diefenbach C; Mellinghoff H; Lynch J; Buzello W
    Anesth Analg; 1992 Mar; 74(3):420-3. PubMed ID: 1311535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course and train-of-four fade of mivacurium block during sevoflurane and intravenous anaesthesia.
    Barrio J; SanMiguel G; Asensio I; Molina I; López F; García V
    Eur J Anaesthesiol; 2005 Apr; 22(4):303-6. PubMed ID: 15892410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery.
    Connolly FM; Mirakhur RK; Loan PB; McCoy EP; Symington M; Kumar N
    Br J Anaesth; 1995 Feb; 74(2):229-30. PubMed ID: 7696074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.